vs

Side-by-side financial comparison of Civeo Corp (CVEO) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $150.6M, roughly 1.1× GLAUKOS Corp). GLAUKOS Corp runs the higher net margin — 6.2% vs -4.0%, a 10.2% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 7.1%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs -1.4%).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

CVEO vs GKOS — Head-to-Head

Bigger by revenue
CVEO
CVEO
1.1× larger
CVEO
$161.6M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+34.1% gap
GKOS
41.2%
7.1%
CVEO
Higher net margin
GKOS
GKOS
10.2% more per $
GKOS
6.2%
-4.0%
CVEO
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
-1.4%
CVEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVEO
CVEO
GKOS
GKOS
Revenue
$161.6M
$150.6M
Net Profit
$-6.5M
$9.4M
Gross Margin
22.7%
77.9%
Operating Margin
-0.1%
9.0%
Net Margin
-4.0%
6.2%
Revenue YoY
7.1%
41.2%
Net Profit YoY
58.1%
EPS (diluted)
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$161.6M
$143.1M
Q3 25
$170.5M
$133.5M
Q2 25
$162.7M
$124.1M
Q1 25
$144.0M
$106.7M
Q4 24
$151.0M
$105.5M
Q3 24
$176.3M
$96.7M
Q2 24
$188.7M
$95.7M
Net Profit
CVEO
CVEO
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$-6.5M
$-133.7M
Q3 25
$-455.0K
$-16.2M
Q2 25
$-3.3M
$-19.7M
Q1 25
$-9.8M
$-18.1M
Q4 24
$-15.4M
$-33.6M
Q3 24
$-5.1M
$-21.4M
Q2 24
$8.2M
$-50.5M
Gross Margin
CVEO
CVEO
GKOS
GKOS
Q1 26
77.9%
Q4 25
22.7%
-1.1%
Q3 25
25.7%
78.4%
Q2 25
25.3%
78.3%
Q1 25
20.4%
77.2%
Q4 24
18.6%
72.9%
Q3 24
21.4%
76.6%
Q2 24
25.4%
76.4%
Operating Margin
CVEO
CVEO
GKOS
GKOS
Q1 26
9.0%
Q4 25
-0.1%
-97.7%
Q3 25
4.1%
-12.3%
Q2 25
1.7%
-18.3%
Q1 25
-3.8%
-19.4%
Q4 24
-6.7%
-27.2%
Q3 24
0.0%
-25.5%
Q2 24
6.9%
-31.3%
Net Margin
CVEO
CVEO
GKOS
GKOS
Q1 26
6.2%
Q4 25
-4.0%
-93.4%
Q3 25
-0.3%
-12.2%
Q2 25
-2.0%
-15.8%
Q1 25
-6.8%
-17.0%
Q4 24
-10.2%
-31.8%
Q3 24
-2.9%
-22.1%
Q2 24
4.4%
-52.8%
EPS (diluted)
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
$-0.58
$-2.34
Q3 25
$-0.04
$-0.28
Q2 25
$-0.25
$-0.34
Q1 25
$-0.72
$-0.32
Q4 24
$-1.04
$-0.56
Q3 24
$-0.36
$-0.39
Q2 24
$0.56
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$14.4M
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.4M
$670.9M
Total Assets
$477.4M
$893.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$14.4M
$90.8M
Q3 25
$12.0M
$98.2M
Q2 25
$14.6M
$100.8M
Q1 25
$28.4M
$114.3M
Q4 24
$5.2M
$169.6M
Q3 24
$17.9M
$100.1M
Q2 24
$7.4M
$68.1M
Total Debt
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$43.3M
Q3 24
Q2 24
Stockholders' Equity
CVEO
CVEO
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$174.4M
$656.2M
Q3 25
$182.5M
$769.5M
Q2 25
$209.4M
$765.1M
Q1 25
$220.7M
$764.0M
Q4 24
$236.4M
$766.9M
Q3 24
$282.2M
$668.5M
Q2 24
$297.4M
$665.2M
Total Assets
CVEO
CVEO
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$477.4M
$893.5M
Q3 25
$491.1M
$999.4M
Q2 25
$508.8M
$987.0M
Q1 25
$423.8M
$966.2M
Q4 24
$405.1M
$974.8M
Q3 24
$477.6M
$926.5M
Q2 24
$483.2M
$919.7M
Debt / Equity
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.18×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
GKOS
GKOS
Operating Cash FlowLast quarter
$19.3M
Free Cash FlowOCF − Capex
$14.5M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
$19.3M
$6.8M
Q3 25
$13.8M
$-10.1M
Q2 25
$-2.3M
$7.0M
Q1 25
$-8.4M
$-18.5M
Q4 24
$9.5M
$507.0K
Q3 24
$35.7M
$-9.6M
Q2 24
$32.4M
$-18.4M
Free Cash Flow
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
$14.5M
$3.9M
Q3 25
$8.2M
$-11.7M
Q2 25
$-6.8M
$5.8M
Q1 25
$-13.7M
$-20.5M
Q4 24
$1.8M
$-1.2M
Q3 24
$28.2M
$-11.0M
Q2 24
$27.0M
$-20.5M
FCF Margin
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
8.9%
2.7%
Q3 25
4.8%
-8.8%
Q2 25
-4.2%
4.7%
Q1 25
-9.5%
-19.2%
Q4 24
1.2%
-1.2%
Q3 24
16.0%
-11.4%
Q2 24
14.3%
-21.4%
Capex Intensity
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
3.0%
2.0%
Q3 25
3.3%
1.2%
Q2 25
2.8%
0.9%
Q1 25
3.7%
1.8%
Q4 24
5.1%
1.6%
Q3 24
4.2%
1.5%
Q2 24
2.8%
2.2%
Cash Conversion
CVEO
CVEO
GKOS
GKOS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons